Individual who uses such a drug or biological means a unique Medicare Part B beneficiary who was furnished the Part B drug or biological that was covered under Part B during the applicable calendar quarter, identified using final action claims data with dates of service during the calendar year described in 427.101(b)(6) and with allowed charges greater than zero
We are also not proposing any modifications to the language currently at 414.1380(b)(2)(i), generally governing if and how CMS determines a cost measure's benchmark
Eurocirce, una Organizzazione di Produttori dal 1979
[700] The training, administration and monitoring is the same for these alternative blood product treatments as it is for WBT
(ii) A manufacturer must submit the rebate reduction extension request at least 60 calendar days before the start of the second consecutive applicable period to receive consideration for a reduction in the rebate amount owed, if any, in accordance with paragraph (b)(2) of this section, except for when the initial request is made less than 60 calendar days before the end of an applicable period such that the initial rebate reduction is applied to the next applicable period rather than the applicable period in which the event that caused the severe supply chain disruption occurred or began
